CMC Considerations for Developing an Effective mRNA/LNP Therapeutic
Вставка
- Опубліковано 21 лип 2024
- Dr. Akhilesh Bhambhani, Sr. Director of Biologics Drug Product Development at Ultragenyx discusses CMC Considerations for developing an effective mRNA/LNP therapeutic.
Learn more about microfluidic technology: www.precisionnanosystems.com/...
Follow us on LinkedIn: bit.ly/3F9uEiL
Follow us on Twitter: bit.ly/3yBttpW - Наука та технологія